Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS' EQUITY (Details - Pre-funded warrants activity)

v3.26.3
STOCKHOLDERS' EQUITY (Details - Pre-funded warrants activity) - Pre-Funded Common Stock Warrants [Member]
 9 Months Ended
Sep. 30, 2026
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common stock warrants outstanding, beginning balance | shares 3,913,538
Weighted average exercise price outstanding, beginning balance | $ / shares $ 0.00002
Common stock warrants, purchased | shares 2,079,797
Weighted average exercise price, granted/purchased | $ / shares $ 0.00001
Common stock warrants, exercised | shares (4,339,649)
Weighted average exercise price, exercised | $ / shares $ 0.00001
Common stock warrants outstanding, ending balance | shares 1,653,686
Weighted average exercise price outstanding, ending balance | $ / shares $ 0.00002
Intrinsic value, outstanding | $ $ 4,977,554
Common stock warrants, exercisable | shares 1,653,686
Weighted average exercise price, exercisable | $ / shares $ 0.00002
Intrinsic value, exercisable | $ $ 4,977,554